Ambulanc (Shenzhen) Tech. Co., Ltd.

Ambulanc (Shenzhen) Tech. Co. , Ltd. is a Shenzhen-based company specializing in innovative medical devices that enhance emergency and critical care services, providing essential solutions for healthcare professionals worldwide.

Founded in 2001 in Shenzhen, China, Ambulanc (Shenzhen) Tech. Co. , Ltd. focuses on developing advanced medical devices.

The company has successfully completed a total of 3 deals, with the most recent funding round occurring in May 2022, where they raised CNY 25 million from investors Hejiang Management and Zhilai Sci and Tech Co. , Ltd. Their current valuation stands at CNY 2,025 million. Ambulanc (Shenzhen) Tech.

Co. , Ltd. specializes in a comprehensive range of medical devices aimed at enhancing emergency and critical care. Their core product offerings include ventilators, CPR machines, defibrillators, airway management devices, and infusion systems, all designed to support healthcare professionals in critical situations.

The company’s flagship brand, Amoul®, integrates advanced technologies for life support solutions, addressing key challenges in respiratory therapy, cardiopulmonary resuscitation, and anesthesia. These products are utilized by a diverse clientele, including hospitals, emergency response teams, and medical training institutions across over 100 countries, such as the United States, Germany, and Brazil, thereby catering to a global market of healthcare providers and patients in need of life-saving interventions. Ambulanc (Shenzhen) Tech. Co.

, Ltd. generates revenue through direct sales of its medical devices and solutions to healthcare institutions, as well as through partnerships with distributors in various regions. In 2024, the company reported a revenue of CNY 39,324,593. 70 and an EBITDA of CNY 4,697,769.

80. Transactions typically occur on a B2B basis, where hospitals and clinics procure essential equipment under structured agreements that may include bulk purchasing options. Revenue is also bolstered by ongoing contracts with healthcare providers for supply and maintenance of devices, reinforcing the company’s commitment to long-term healthcare solutions. Ambulanc (Shenzhen) Tech.

Co. , Ltd. plans to leverage the recent funding raised in May 2022, amounting to CNY 25 million, to enhance product development and expand into new geographic markets. The company is in the process of designing innovative products aimed at improving life support systems, with potential launches expected in the upcoming year.

Specific target markets for expansion include Southeast Asia and Latin America, with plans to establish a local presence by 2025.